Global Biodefense Market size forecast to exceed $17bn by 2024
The emergence of technologically advanced centers for innovation in advanced development and manufacturing, continuous development of next generation detection systems such as CIP based detection, environmental detection and vulnerability detection is anticipated to drive revenue.
Request for a sample of this research report – https://www.gminsights.com/request-sample/detail/714
Global surveillance measures against the threats of bioterrorism and pandemic outbreaks has improved public health preparedness to effectively monitor and control community health. The focus is shifted towards development of precise analytical instruments, tests and procedures that detects and identifies bio threat agents. Countries have entered into mass production and stockpiling of antibiotics effective against the bacterial agents and resumed the halted offensive biological weapons programs.
Protective measures implemented by international associations will serve as strategic deterrents. For instance, a treaty between U.S. and North Atlantic Treaty Organization (NATO) reinstates the commitment of the use of weapons of mass destruction against any member state would represent an attack against all NATO members. Other protective and instant response measures include development of the CDC Rapid Response and Advanced Technology laboratory, National Electronic Data Surveillance System (NEDSS), Health Alert Network (HAN), and Epidemic Information Exchange (Epi-X). These protective measures are anticipated to reduce the cost of responding to any emergency bio threat.
North America biodefense market share represented the largest regional segment in 2015. Implementation of Project BioShield coupled with presence of government and private funding are some of the factors fueling demand. Furthermore, countries such as Japan and China should experience high growth in the coming years due to advancing healthcare infrastructure, and the presence of favorable political and regulatory environment.
Browse key industry insights spread across 82 pages with 30 market data tables & 8 figures & charts from the report, “Biodefense Market Size By Product (Anthrax, Small Pox, Botulism, Radiation/ Nuclear), Industry Analysis Report, Regional Outlook (U.S., Canada, U.K, Germany, China, Japan, Mexico, Brazil, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents:
Key insights from the report include:
- Global biodefense market size was driven by the anthrax segment, which was USD 3 billion in 2015 and is anticipated to grow at 5% from 2016 to 2024.
- Revenue growth will be propelled by smallpox segment that is set to increase at 7.4% CAGR estimations to exceed USD 4 billion by 2024.
- Eminent companies entered into contracts with the government for addressing a range of healthcare, scientific, national security and international security issues, which has led to high U.S. biodefense market share.
- European countries of Germany and UK are set to witness lucrative growth rate due to designated funding policies in place.
Companies operating in the industry include Xoma Corporation, Emergent Biosolutions, Cleveland BioLabs, Nanotherapeutics, SIGA Technologies, etc. Presence of extensive product portfolio and strong pipeline will contribute to profitability.